D006397Chemicals & DrugsD27.505.954.502.543550.993492Hematinicsprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25256386Pirkle JL, Paoli CJ, Russell G, Petersen J, Burkart JClinical therapeuticsPirkle JL, Paoli CJ, Russell G, Petersen J, Burkart J. Hemoglobin stability and patient compliance with darbepoetin alfa in peritoneal dialysis patients after the implementation of the prospective payment system. Clin Ther. 2014 Nov 01; 36(11):1665-74.Clin Ther2014-09-23T00:00:002014Hemoglobin stability and patient compliance with darbepoetin alfa in peritoneal dialysis patients after the implementation of the prospective payment system.Wake Forest School of MedicineJamesPirkleJames L. Pirkle MD36.08959100000000-80.268599000000001173Pirkle, JamesAssociate ProfessorElsayedSolimanElsayed Z. Soliman MD, MS36.09550200000000-80.24393700000000281Soliman, ElsayedProfessorM GracaAlmeida-PoradaM Graca N. Almeida-Porada MD, PhD36.08943500000000-80.26863200000000297Almeida-Porada, M GracaProfessorBarryFreedmanBarry I. Freedman MD36.08959100000000-80.2685990000000078Freedman, BarryProfessorShahriarMoossaviShahriar Moossavi MD, PhD36.08959100000000-80.26859900000000917Moossavi, ShahriarAssociate ProfessorInternal Medicine, Cardiovascular MedicineInternal Medicine, NephrologyWake Forest Institute for Regenerative Medicine32003597Chiloff DM, de Almeida DC, Dalboni MA, Canziani ME, George SK, Morsi AM, El-Akabawy N, Porada CD, Durao MS, Zarjou A, Almeida-Porada G, Goes MAAmerican journal of physiology. Renal physiologyChiloff DM, de Almeida DC, Dalboni MA, Canziani ME, George SK, Morsi AM, El-Akabawy N, Porada CD, Durao MS, Zarjou A, Almeida-Porada G, Goes MA. Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease. Am J Physiol Renal Physiol. 2020 04 01; 318(4):F861-F869.Am J Physiol Renal Physiol2020-01-31T00:00:002020Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessor20933538Viera AJ, Sheridan SL, Edwards T, Soliman EZ, Harris R, Furberg CDPreventive medicineViera AJ, Sheridan SL, Edwards T, Soliman EZ, Harris R, Furberg CD. Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Prev Med. 2011 Jan; 52(1):10-5.Prev Med2010-10-08T00:00:002010Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.23332991Brunelli SM, Monda KL, Burkart JM, Gitlin M, Neumann PJ, Park GS, Symonian-Silver M, Yue S, Bradbury BD, Rubin RJAmerican journal of kidney diseases : the official journal of the National Kidney FoundationBrunelli SM, Monda KL, Burkart JM, Gitlin M, Neumann PJ, Park GS, Symonian-Silver M, Yue S, Bradbury BD, Rubin RJ. Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). Am J Kidney Dis. 2013 Jun; 61(6):947-56.Am J Kidney Dis2013-01-15T00:00:002013Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS).19546408Moossavi S, Freedman BIArchives of internal medicineMoossavi S, Freedman BI. Treating anemia with erythropoiesis-stimulating agents: effects on quality of life. Arch Intern Med. 2009 Jun 22; 169(12):1100-1.Arch Intern Med2009-06-22T00:00:002009Treating anemia with erythropoiesis-stimulating agents: effects on quality of life.0.5165990.02453915research area of0.5199830.08590376subject area for